Cango (NYSE:CANG) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $(0.07) by 57.14 percent. This is a 73.81 percent increase over losses of $(0.42) per share from the same period last year.
ClearPoint Neuro Announces Installation And First Procedure Using The ClearPoint Prism Neuro Laser Therapy System And Navigation System At Kaleida Health In Buffalo
ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced installation and completion of an initial
